JENNA RICE: Open Payments
NPI 1336622463 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 36 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $330 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $667 |
| Gilead Sciences, Inc. | 15 | $605 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $114 |
| Janssen Biotech, Inc. | 3 | $73 |
| ABBVIE INC. | 2 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
Products named: REZDIFFRA, Livdelzi, XIFAXAN, TREMFYA, IQIRVO, SKYRIZI, LINZESS.
Industry payments across MD — which companies pay providers there.
